InsiderTrades

Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP

Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-10 · accession 0000917520-24-000025 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-12 2024-03-10 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 +346 18.7K +2% $0
D 2024-03-12 2024-03-10 IART De Witte Jan Pres, CEO, Dir F - Tax $36.73 -346 18.4K -2% -$12.7K
D 2024-03-12 2024-03-10 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 -346 89.1K -0.4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-10 M A 346 $0.00 18,696 D — —
2 Common Common Stock 2024-03-10 F D 346 $36.73 18,350 D — —
3 Derivative Restricted Stock Units 2024-03-10 M D 346 $0.00 89,071 D $0.00 · — to — 346 Common Stock (F1) The award was a restricted stock unit award which will vest in three equal annual installments on the first, second and third anniversaries of the grant date of 3/10/2023 which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six month period after the date of his separation of service as deferred compensation. The award is subject to accelerated vesting upon termination of employment by reason of death or disability or upon a qualifying termination on or within 24 months following the date of a change in control.